Cytek Biosciences (CTKB) Net Income (2020 - 2026)
Cytek Biosciences' (CTKB) quarterly Net Income came in at -$18.9 million in Q1 2026, down 65.52% YoY from -$54.7 million in Q1 2025, and up 57.14% on a QoQ basis from -$44.0 million in Q4 2025.
Cytek Biosciences (CTKB) Net Income (2020 - 2026) Analysis & Trends
Cytek Biosciences (CTKB) has 7 years of Net Income data on file, last reported at -$18.9 million in Q1 2026.
- Quarterly Net Income fell 65.52% year-over-year to -$18.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$74.0 million (down 555.85% YoY) and the FY2025 annual result came in at -$66.5 million, down 1005.3% from the prior year.
- Net Income rose to -$18.9 million in Q1 2026, from -$44.0 million in the prior quarter.
- In the past five years, Net Income ranged from a high of $9.6 million in Q4 2024 to a low of -$44.0 million in Q4 2025.
- A 5-year average of -$5.9 million and a median of -$5.5 million in 2025 frame the typical range for Net Income.
- The widest YoY moves for Net Income: up 419.14% in 2022, down 2215.69% in 2022.
- Tracing CTKB's Net Income over 5 years: stood at $3.7 million in 2022, then surged by 48.01% to $5.5 million in 2023, then jumped by 74.5% to $9.6 million in 2024, then slumped by 558.49% to -$44.0 million in 2025, then soared by 57.14% to -$18.9 million in 2026.
- The last three Net Income figures came in at -$18.9 million (Q1 2026), -$44.0 million (Q4 2025), and -$5.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | 618.38 Mn |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Cytek Biosciences | 611.56 Mn | 537.71 Mn | 28.34 Mn | -12.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -12.16 Mn |
| Mar 31, 2026 | -18.87 Mn |
| Dec 31, 2025 | -44.03 Mn |
| Sep 30, 2025 | -5.47 Mn |
| Jun 30, 2025 | -5.58 Mn |
| Mar 31, 2025 | -11.40 Mn |
| Dec 31, 2024 | 9.60 Mn |
| Sep 30, 2024 | 957,000.00 |
| Jun 30, 2024 | -10.43 Mn |
| Mar 31, 2024 | -6.19 Mn |
| Dec 31, 2023 | 5.50 Mn |
| Sep 30, 2023 | -6.46 Mn |
| Jun 30, 2023 | -4.40 Mn |
| Mar 31, 2023 | -6.84 Mn |
| Dec 31, 2022 | 3.72 Mn |
| Sep 30, 2022 | 1.63 Mn |
| Jun 30, 2022 | -702,000.00 |
| Mar 31, 2022 | -2.16 Mn |
| Dec 31, 2021 | -1.17 Mn |
| Sep 30, 2021 | 1.42 Mn |